- Nasal Spray
- Cream
- Ointment
- Inhalers
- Others
Mometasone Furoate Market size was valued at USD 1,198.4 million in 2023 and is poised to grow at a CAGR of 7.5% from 2024 - 2030. Mometasone also called mometasone furoate is a corticosteroid that is used to cure hay fever, asthma, and numerous skin issues. Instead of handling asthma attacks, mometasone furoate is used chiefly to avoid them. It prevents white blood cells (WBCs) which fight against infection from reaching the injured area. Mometasone reduces itching, redness, and inflammation. It hinders the chemical messenger, histamine, which is responsible for allergic reactions in the body. Symptoms of various skin allergies along with other allergic disorders like allergic rhinitis and hay fever are efficient for treatment by mometasone furoate. The rising prevalence of inflammatory skin diseases can lead to the mometasone furoate market growth. Moreover, the growth in the geriatric populace and growing personal aesthetics are some primary factors that can boost the global mometasone furoate market. Apart from these, the rising patient populace suffering from asthma can also accelerate the market in the future. The growing cooperative research and development events among leading pharmaceutical filtration and biotechnological companies can also drive the global market further. However, some factors such as side effects related to mometasone furoates such as sore throat, headache, nose bleeds, muscle and joint pain, viral upper respiratory infections, and cough can restrain the growth of the market.
Mometasone Furoate Market Key Developments:
- In June 2022, Glenmark launched Indacaterol and Mometasone Fixed-Dose Combination Drug for the treatment of asthma and became the first pharmaceutical company
- In May 2021, Glenmark launched Ryaltris-AZ nasal spray for the treatment of moderate to severe allergic rhinitis.
Mometasone Furoate Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
7.5%
Largest Market
North America
Fastest Growing Market
Asia pacific
Mometasone Furoate Market Dynamics
One of the major reasons for the global mometasone furoate market growth is the growing research and development actions connected to mometasone furoate. According to the research published in the Journal of Dermatological Treatment, March 2022, a study was conducted to develop aspasomal mometasone furoate gel that delivers medicine at a controlled rate, needs nominal doses to cure psoriasis, and is biologically active. Aspasomal gel along with mometasone furoate was formulated and it was observed that aspasomal gel along with mometasone furoate delivered the medicine after a longer time period and needed fewer doses, increasing the possibility of psoriasis treatment.
North America Got Significant Share
Mometasone Furoate Market Regional Analysis
North America is dominating the global mometasone furoate market, due to. a high degree of commercialization and approvals of pharmaceutical drugs. Moreover, an increase in research and development activities in the biotechnology and pharmaceutical sector, and increasing awareness and presence of technologically advanced devices have also attributed to the growth of the market. In addition, Asia Pacific is one of the most profitable regions and is generating new prospects for global players. The increasing prevalence of inflammatory skin diseases and the growing population of patients in the region which has the potential to increase the demand for mometasone furoate in these regions. Apart from this, the rising number of indigenous manufacturers has created a demand for the use of mometasone furoate.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Mometasone Furoate Market Segmentation
By Dosage Form
By Indication Type
- Inflammatory Skin Disorders
- Asthma
- Allergic rhinitis
- Others
By Route Administration
- Nasal Administration
- Topical
- Oral
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Frequently Asked Questions
The Mometasone Furoate Market size was valued at USD 1,198.4 million in 2023
Cipla, Teva Pharmaceuticals, Glenmark Pharmaceuticals, AdvaCare Pharma, Medlab Pharmaceuticals Private Limited, Dermocare Laboratories, Iva Healthcare Private Limited, Organon group of companies, Cosette Pharmaceuticals, Taro Pharmaceutical Industries Ltd., Hikma Pharmaceuticals
North America is the fastest-growing region for mometasone furoate market
| 1. Executive Summary |
| 2. Global Mometasone Furoate Market Introduction |
| 2.1. Global Mometasone Furoate Market Taxonomy |
| 2.2. Global Mometasone Furoate Market Definitions |
| 2.2.1. Dosage Form |
| 2.2.2. Indication Type |
| 2.2.3. Route of administration |
| 2.2.4. Distribution Channel |
| 2.2.5. By Region |
| 3. Global Mometasone Furoate Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Mometasone Furoate Market Dynamic Factors - Impact Analysis |
| 3.6. Global Mometasone Furoate Market Competition Landscape |
| 3.7. Epidemiology |
| 4. Global Mometasone Furoate Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Mometasone Furoate Market, By Dosage Form, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1. Nasal Spray |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Cream |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Ointment |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Inhalers |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Mometasone Furoate Market, By Indication Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1. Inflammatory Skin Disorders |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Asthma |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Allergic rhinitis |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Mometasone Furoate Market, By Route of Administration, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1. Nasal Administration |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Topical |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Oral |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Mometasone Furoate Market, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1. Hospital Pharmacies |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Retail Pharmacies |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Online Pharmacies |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Mometasone Furoate Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Mometasone Furoate Market - Opportunity Analysis Index, By Dosage Form, By Indication Type, By Route of Administration, By Distribution Channel, and Region, 2024 - 2030 |
| 10. North America Mometasone Furoate Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 10.1. Dosage Form Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Nasal Spray |
| 10.1.2. Cream |
| 10.1.3. Ointment |
| 10.1.4. Inhalers |
| 10.1.5. Others |
| 10.2. Indication Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Inflammatory Skin Disorders |
| 10.2.2. Asthma |
| 10.2.3. Allergic rhinitis |
| 10.2.4. Others |
| 10.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Nasal Administration |
| 10.3.2. Topical |
| 10.3.3. Oral |
| 10.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. Hospital Pharmacies |
| 10.4.2. Retail Pharmacies |
| 10.4.3. Online Pharmacies |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Mometasone Furoate Market - Opportunity Analysis Index, By Dosage Form, By Indication Type, By Route of Administration, By Distribution Channel, and Country, 2024 - 2030 |
| 10.7. North America Mometasone Furoate Market Dynamics Trends |
| 11. Europe Mometasone Furoate Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 11.1. Dosage Form Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Nasal Spray |
| 11.1.2. Cream |
| 11.1.3. Ointment |
| 11.1.4. Inhalers |
| 11.1.5. Others |
| 11.2. Indication Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Inflammatory Skin Disorders |
| 11.2.2. Asthma |
| 11.2.3. Allergic rhinitis |
| 11.2.4. Others |
| 11.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Nasal Administration |
| 11.3.2. Topical |
| 11.3.3. Oral |
| 11.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. Hospital Pharmacies |
| 11.4.2. Retail Pharmacies |
| 11.4.3. Online Pharmacies |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Rest of Europe |
| 11.6. Europe Mometasone Furoate Market - Opportunity Analysis Index, By Dosage Form, By Indication Type, By Route of Administration, By Distribution Channel, and Country, 2024 - 2030 |
| 11.7. Europe Mometasone Furoate Market Dynamics Trends |
| 12. Asia-Pacific Mometasone Furoate Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 12.1. Dosage Form Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Nasal Spray |
| 12.1.2. Cream |
| 12.1.3. Ointment |
| 12.1.4. Inhalers |
| 12.1.5. Others |
| 12.2. Indication Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Inflammatory Skin Disorders |
| 12.2.2. Asthma |
| 12.2.3. Allergic rhinitis |
| 12.2.4. Others |
| 12.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Nasal Administration |
| 12.3.2. Topical |
| 12.3.3. Oral |
| 12.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1. Hospital Pharmacies |
| 12.4.2. Retail Pharmacies |
| 12.4.3. Online Pharmacies |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. Japan |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Mometasone Furoate Market - Opportunity Analysis Index, By Dosage Form, By Indication Type, By Route of Administration, By Distribution Channel, and Country, 2024 - 2030 |
| 12.7. Asia-Pacific Mometasone Furoate Market Dynamics Trends |
| 13. Latin America Mometasone Furoate Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 13.1. Dosage Form Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Nasal Spray |
| 13.1.2. Cream |
| 13.1.3. Ointment |
| 13.1.4. Inhalers |
| 13.1.5. Others |
| 13.2. Indication Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Inflammatory Skin Disorders |
| 13.2.2. Asthma |
| 13.2.3. Allergic rhinitis |
| 13.2.4. Others |
| 13.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Nasal Administration |
| 13.3.2. Topical |
| 13.3.3. Oral |
| 13.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1. Hospital Pharmacies |
| 13.4.2. Retail Pharmacies |
| 13.4.3. Online Pharmacies |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Mometasone Furoate Market - Opportunity Analysis Index, By Dosage Form, By Indication Type, By Route of Administration, By Distribution Channel, and Country, 2024 - 2030 |
| 13.7. Latin America Mometasone Furoate Market Dynamics Trends |
| 14. Middle East and Africa Mometasone Furoate Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 14.1. Dosage Form Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Nasal Spray |
| 14.1.2. Cream |
| 14.1.3. Ointment |
| 14.1.4. Inhalers |
| 14.1.5. Others |
| 14.2. Indication Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Inflammatory Skin Disorders |
| 14.2.2. Asthma |
| 14.2.3. Allergic rhinitis |
| 14.2.4. Others |
| 14.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1. Nasal Administration |
| 14.3.2. Topical |
| 14.3.3. Oral |
| 14.4. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1. Hospital Pharmacies |
| 14.4.2. Retail Pharmacies |
| 14.4.3. Online Pharmacies |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. South Africa |
| 14.5.3. Rest of MEA |
| 14.6. MEA Mometasone Furoate Market- Opportunity Analysis Index, By Dosage Form, By Indication Type, By Route of Administration, By Distribution Channel, and Country, 2024 - 2030 |
| 14.7. MEA Mometasone Furoate Market Dynamics Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Key Dosage Forms, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Cipla |
| 15.2.2. Teva Pharmaceuticals |
| 15.2.3. Glenmark Pharmaceuticals |
| 15.2.4. AdvaCare Pharma |
| 15.2.5. Medlab Pharmaceuticals Private Limited |
| 15.2.6. Dermocare Laboratories |
| 15.2.7. Iva Healthcare Private Limited |
| 15.2.8. Organon group of companies |
| 15.2.9. Cosette Pharmaceuticals |
| 15.2.10. Taro Pharmaceutical Industries Ltd. |
| 15.2.11. Hikma Pharmaceuticals |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
- Cipla
- Teva Pharmaceuticals
- Glenmark Pharmaceuticals
- AdvaCare Pharma
- Medlab Pharmaceuticals Private Limited
- Dermocare Laboratories
- Iva Healthcare Private Limited
- Organon group of companies
- Cosette Pharmaceuticals
- Taro Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals